You are here: Industry Insights > Diabetes

News List

Diabetes drugs aid macrophages to control inflammation europeanpharmaceuticalreview
April 19, 2019
Dr Lazar’s team identified that TZDs, while working for PPAR gamma, promoted the metabolism of glutamine, an amino acid…
No 'One-Size-Fits-All' Diet for Diabetics, Expert Panel Says drugs
April 19, 2019
There is no one right diet for people with diabetes, and patients should instead have personalized nutrition plans, a new American Diabetes Association (ADA) report says.
Most Diabetes Phone Apps Lack Education, Support Functions drugs
April 18, 2019
Most Diabetes Phone Apps Lack Education, Support Functions.
A new molecule to improve treatment for type 2 diabetes and non-alcoholic fatty liver disease firstwordpharma
April 11, 2019
A new molecule to improve treatment for type 2 diabetes and non-alcoholic fatty liver disease.
Sanofi plans sales layoffs—again—in primary care, diabetes fiercepharma
April 04, 2019
Sanofi has been hit hard by pricing pressure in diabetes, and now the drugmaker’s U.S. sales force is set for another round of job cuts.
Cigna's Express Scripts to cap out-of-pocket insulin costs at $25 per month in US firstwordpharma
April 04, 2019
Health insurer Cigna and its pharmacy benefit manager (PBM) arm Express Scripts announced Wednesday the launch of a programme in the US designed to ensure that eligible patients with diabetes in participating plans pay no more than $25 for a 30-day supply
Fresh off new Farxiga data, AstraZeneca diabetes push points up cardiovascular, renal risks fiercepharma
April 02, 2019
AstraZeneca has been pumping dollars into studying its Type 2 diabetes drugs and their ability to stave off complications like heart disease and kidney problems……
Pfizer Study Finds Progress in Combating Fatty Liver firstwordpharma
March 28, 2019
Pfizer unveiled mid-stage study results illustrating that a drug that prevents the body from metabolising fructose significantly reduced liver fat, Bloomberg reported Wednesday.
Gelesis Presents Expanded Data Showing Impact of Gelesis100 Hydrogel on Patients with Prediabetes, Untreated Diabetes, and Elevated Insulin firstwordpharma
March 26, 2019
Gelesis, a biotechnology company developing first-in-class mechanotherapeutics to treat obesity and other chronic diseases related to……
FDA Approves Sunosi (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea drugs
March 21, 2019
Jazz Pharmaceuticals plc today announced that the U.S. Food and Drug Administration (FDA) approved Sunosi (solriamfetol) to improve wakefulness in adult patients with excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea (OSA)

Previous page 1 2 3 4 5 6 7 8 9 10 ... 38 39 Next page